Breaking News

Ardena Acquires ChemConnection

Adds API expertise as part of strategy to form a leading integrated drug development company

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Contract development and manufacturing organization (CDMO) Ardena has acquired ChemConnection, a leading contract manufacturer of novel active pharmaceutical ingredients (APIs) and nanomedicines. Originating from Organon and Merck Sharp & Dohme (MSD) in 2012, Netherlands-based ChemConnection has evolved to become a well-respected contract services provider serving biotechs and mid-sized pharmaceutical companies on a global scale. This announcement follows a series of acquisitions by Be...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters